KKR

TPG is evaluating a dual-track exit for Asia OneHealthcare, targeting a valuation of approximately RM30 Bn through an IPO or a trade sale. Although the healthcare operator offers significant scale, its valuation will depend on how public and private markets weigh its rapid expansion against near-term financial loss.

A public listing will test whether Nvidia's ecosystem funding is a genuine value creator or a circular financing loop.

AI investment, cross-border M&A, retail divestment, digital infrastructure, renewable energy, and legal developments drive Asia-Pacific business activity.